Subject Index  by unknown








Abciximab 1100-277 · A108
Ablation 1079-136 · A5
Ablation, alcohol septal 2907-05 · A181
Ablation, atrial fibrillation 1080-138 · A6
Ablation, catheter 1133-126 · A7
Ablation, radiofrequency 1136-146 -· A9
Accuracy, diagnostic 1145-205 · A80
Activated clotting time 2504-433 · A206
Acute coronary syndromes 1154-266 · 
A113
Acute coronary syndromes, 
management 1045-279 · A102
Acute myocardial infarction 1098-259 · 
A106
Adenosine 0408-4 · A223
Adhesion molecules 2501-464 · A188
Adipokines 1018-92 · A48
Adiponectin 1217-321 · A123
Adipose tissue 1038-230 · A70
Adult congenital heart disease 0907-06 
· A39
Adverse event rates 1021-113 · A50
Adverse events 1083-163 · A133
Aerobic capacity 1143-188 · A79
African American 1020-103 · A49
Age 2501-447 · A187
Aging 1209-269 · A119
Aging, vascular 1240-104 · A61
Albumin 1124-68 · A29
Albuminuria 1017-90 · A48
Algorithm 2505-531 · A217
Allogeneic mesenchymal cell 2505-507 · 
A216
Alternative medicine 1221-352 · A171
Amyloidosis 1198-193 · A85
Amyloidosis, cardiac 1016-85 · A22
Anemia 1143-193 · A79
Anemia, association with chronic kidney 
disease 1179-64 · A33
Aneurysm 1185-106 · A59
Aneurysm, ascending aorta 1111-350 · 
A161
Angina pectoris 1217-322 · A123
Angina, refractory 1212-290 · A120
Angina, variant 1102-291 · A109
Angiogenesis 1014-68 · A20
Angiographic follow-up 2501-515 · A191
Angiography 2505-534 · A217
Angiography, invasive cardiac 1171-383 · 
A149
Angioplasty 2503-435 · A200
Angioplasty, primary 2909-08 · A183
Angioscopy 2908-10 · A182
Angiotensin II 0402-01 · A222
Angiotensin-converting enzyme 1122-51 
· A27
Angiotensin-converting enzyme 
inhibitors 1239-98 · A61
Angiotensin-receptor blockers 1239-98 · 
A61
Ankle-brachial index 1056-356 · A157
Anthracycline 1257-225 · A94
Antiarrhythmic agents 0903-05 · A1
Antibodies 1278-376 · A152
Anticoagulants 1224-371 · A172
Anticoagulants, oral 1229-404 · A44
Anticoagulation 1224-374 · A173
Antihypertensive medications 1238-96 · 
A61
Antioxidative effects 1274-352 · A175
Antiplatelet therapy 1154-266 · A113
Antithrombin agent 1224-373 · A172
Antithrombotic therapy 1045-274 · A101
Aorta 0909-03 · A64
Aortic aneurysm 1063-398 · A40
Aortic annulus 0909-06 · A65
Aortic disease 1063-393 · A40
Aortic dissection 1111-352 · A161
Aortic distensibility index 1063-393 · A40
Aortic imaging 1144-204 · A80
Aortic pressure 1113-366 · A163
Aortic regurgitation 1278-375 · A151
Aortic size 1144-204 · A80
Aortic stenosis 1280-397 · A45
Aortic stenosis, asymptomatic 1172-390 
· A150
Aortic stenosis, degenerative 1225-375 · 
A150
Aortic stenosis, medical 
management 1170-379 · A149
Aortic stiffness 1278-375 · A151
Aortic stiffness, persistent 1108-329 · 
A160
Aortic valve 0909-03 · A64
Aortic valve calcification 1090-205 · A74
Aortic valve disease 1171-384 · A149
Aortic valve replacement 1226-385 · A151
Aortic valve replacement, 
mechanical 2505-436 · A212
Apical ballooning 1121-43 · A27
Apolipoprotein 1076-109 · A53
Apolipoprotein A-I 1128-96 · A55
Apolipoprotein AI-Milano 1278-378 · A152
Apolipoprotein B-100 1075-107 · A53
Apoptosis 1078-126 · A5
Appropriateness criteria 1031-177 · A132
Arrhythmia 1078-127 · A5
Arrhythmia, atrial 0907-06 · A39
Arrhythmia, mechanisms 1190-140 · A11
Arrhythmia, tachycardia 1134-129 · A8
Arrhythmia, treatment 1246-153 · A15
Arrhythmia, ventricular 1099-265 · A107
Arrhythmogenic right ventricular 
cardiomyopathy 1230-35 · A35
Arterial elasticity 1242-118 · A63
Arterial stiffness 1021-109 · A50
Arteriogenesis 1001-18 · A219
Arteriosclerosis 1108-329 · A160
Artery 0915-05 · A153
Aspirin 1195-173 · A140
Aspirin resistance 1100-280 · A108
Asymmetric dimethylarginine 1056-356 · 
A157
Atherectomy 2505-452 · A213
Atheroma burden 1271-324 · A173
Atherosclerosis 0921-03 · A153
Atherosclerosis, coronary 1145-209 · A81
Atherosclerotic burden 1119-401 · A42
Athlete 1114-373 · A164
Athlete’s heart 1144-204 · A80
Atorvastatin 1022-118 · A51
Atrial arrhythmia 1133-125 · A7
Atrial fibrillation 0903-06 · A1
Atrial fibrillation, association with heart 
failure 1198-194 · A85
Atrial fibrillation, chronic 1256-215 · A93
Atrial fibrillation, persistent 1134-132 · A8
Atrial fibrillation, prevention 1244-136 · 
A13
Atrial flutter 1097-255 · A79
Atrial natriuretic peptide 1045-276 · A101
Atrial septal defect 2505-430 · A212
Augmentation index 1177-48 · A31
Autoimmune 1122-50 · A27
Autonomic function 1177-47 · A31
Autonomic nerve 1027-155 · A130
AZD6140 1264-266 · A124
B-type natriuretic peptide 1167-359 · A167
Bare-metal stent 1043-256 · A100
Bare-metal stent, restenosis 1268-307 · 
A127
Bariatric surgery 1165-347 · A166
Baroreflex sensitivity 1099-268 · A107
Beta blockers 1235-70 · A37
Beta-1 adrenergic receptor 
polymorphism 1029-170 · A131
Bevacizumab 1155-276 · A114
Bicuspid aortic valve 1063-395 · A40
Bifurcation 2505-490 · A215
Bifurcation angle 2503-432 · A199
Bifurcation lesion 2503-501 · A203
Bifurcation stenting 2503-430 · A199
Bifurcation, left main coronary 
artery 2502-498 · A196
Bioabsorbable polymer 2505-523 · A217
Bioabsorbable polymer, 
salicylate-based 1086-179 · A135
Biodegradable polymer 2505-522 · A217
JACC    March 9, 2010  Subject Index A311 
Subject Index
Clinical pathways 1197-184 · A141
Clinical practice 1141-179 · A138
Clinical profiles 1221-356 · A171
Clinical quality 1083-162 · A133
Clinical trial, randomized, double-blind, 
placebo-controlled 1197-185 · A141
Clinical trials 1195-174 · A140
Clopidogrel 2504-436 · A206
Clopidogrel efficacy 2504-437 · A206
Clopidogrel loading 2504-429 · A205
Clopidogrel resistance 2504-453 · A207
Clopidogrel response variability 2504-453 
· A207
Coarctation of the aorta 1063-398 · A40
Cohort 1182-87 · A57
Collagen 1232-48 · A36
Collagen metabolism 1258-229 · A94
Collateral circulation 1054-337 · A156
Collateral flow 2503-523 · A205
Comparative study 1270-321 · A128
Complex lesion 2504-494 · A209
Compliance 1154-265 · A113
Compliance with published 
guidelines 1031-177 · A132
Complication 1064-404 · A41
Complications, interventional 
procedures 2502-514 · A197
Computational modeling 1087-185 · A135
Computed tomography 2505-433 · A212
Computed tomography 
angiography 0905-05 · A64
Computed tomography coronary 
angiography 1034-198 · A68
Computed tomography, 320 detector-row 
volume 1033-194 · A67
Computed tomography, 64-slice 1033-192 
· A67
Computed tomography, calcium score, 
diagnostic ability 1042-251 · A72
Computed tomography, cardiac 1041-247 
· A72
Computed tomography, dual 
energy 1230-38 · A35
Computed tomography, electron 
beam 1040-240 · A71
Computed tomography, multiple 
detector-row/multislice 1034-198 · A68
Computed tomography, prospective 
electrocardiogram triggering 1001-8 · 
A218
Computer 1224-374 · A173
Computer-aided quantitation 0905-05 · 
A64
Congenital heart disease 1281-407 · A46
Congenital heart disease, adult 1063-398 
· A40
Congestive heart failure 1244-136 · A13
Constrictive pericarditis 1122-47 · A27
Contractility 1002-25 · A220
Biomarker 1099-272 · A108
Biomarkers, inflammatory 1098-259 · 
A106
Bioprosthetic aortic valve 
replacement 1117-391 · A148
Bivalirudin 2504-422 · A205
Biventricular pacing 1126-79 · A30
Bleeding 2504-432 · A206
Blood pressure 1020-103 · A49
Blood pressure, central 1237-88 · A60
Blood pressure, systolic 0925-03 · A154
Blood transfusion 1011-44 · A18
Body mass index 1265-274 · A125
Bone marrow mesenchymal stem 
cells 1013-56 · A19
Bone marrow stem cells 1275-360 · A176
Bosentan 1223-364 · A172
Brain natriuretic peptide 1201-214 · A87
Bundle branch block 1099-266 · A107
Bypass operation 2502-503 · A197
C-reactive protein 1022-119 · A51
C-reactive protein, 
high-sensitivity 1112-362 · A163
Calcification 1034-204 · A68
Calcium current 0402-02 · A222
Calcium-channel blockers 1239-102 · A61
Cancer 1155-276 · A114
Carcinoid heart disease 1257-224 · A94
Cardiac arrest 1188-126 · A10
Cardiac catheterization 1174-407 · A43
Cardiac catheterization, right 
heart 1120-38 · A26
Cardiac death 1181-85 · A34
Cardiac dysfunction 1119-404 · A42
Cardiac function 1152-253 · A84
Cardiac hemodynamics 1001-11 · A218
Cardiac hypertrophy 1014-68 · A20
Cardiac imaging 1034-204 · A68
Cardiac magnetic resonance 
imaging 1094-235 · A77
Cardiac magnetic resonance imaging, 
delayed enhancement 0408-3 · A223
Cardiac output 1173-395 · A42
Cardiac pacing 1024-132 · A3
Cardiac rehabilitation 1187-119 · A60
Cardiac resynchronization therapy 1065-37 
· A22
Cardiac risk factors 1090-208 · A75
Cardiac sarcoidosis 1150-241 · A83
Cardiac shock 2505-431 · A212
Cardiac surgery 1110-344 · A161
Cardiac syndrome X 1148-228 · A82
Cardiogenic shock 1052-320 · A106
Cardiomyocyte energetics 1104-302 · 
A110
Cardiomyocytes 0402-01 · A222
Cardiomyogenic differentiation 1013-56 · 
A19
Cardiomyopathy 1173-393 · A42
Cardiomyopathy, dilated 1230-37 · A35
Cardiomyopathy, idiopathic 
dilated 1121-41 · A27
Cardiomyopathy, inflammatory 1014-63 · 
A20
Cardiomyopathy, ischemic 1191-149 · A12
Cardiomyopathy, restrictive 1177-51 · A32
Cardiomyopathy, stress-induced 1035-211 
· A69
Cardiopulmonary exercise test 1146-218 
· A81
Cardiorenal syndrome 1179-63 · A33
Cardiotoxicity 1177-49 · A32
Cardiovascular 1028-164 · A131
Cardiovascular disease 1114-370 · A163
Cardiovascular event 1277-374 · A177
Cardiovascular morbidity 1168-367 · A167
Cardiovascular phenotype 1166-357 · 
A166
Cardiovascular risk factor 1076-112 · A53
Cardiovascular risk reduction 1002-28 · 
A220
Cardiovascular surgery 0924-04 · A98
Cardioversion 1078-124 · A4
Carotid artery 1167-358 · A167
Carotid artery stenting 1110-344 · A161
Carotid atherosclerosis 1017-86 · A48
Carotid intima-media thickness 0921-03 
· A153
Carotid stenosis 1110-342 · A161
Catheter ablation 1190-137 · A11
Catheterization 1280-397 · A45
Cell therapy 1276-367 · A176
Central pressures 1240-106 · A62
Cerebral blood flow, calculation 
of 1026-147 · A4
Cerebrovascular disease 1012-49 · A19
CHADS2 score 0903-04 · A1
Chelation therapy 1003-552 · A221
Chemotherapy 1135-142 · A9
Chest pain 1208-261 · A118
Chest pain, acute ischemic 1265-280 · 
A125
Children 1184-102 · A58
Cholesterol 1246-150 · A15
Cholesterol-lowering therapy 1131-110 · 
A56
Chronic obstructive pulmonary 
disease 1084-167 · A134
Chronic thromboembolic pulmonary 
hypertension 1222-361 · A171
Chronic total occlusion 1161-313 · A117
Chronotropic 1068-56 · A24
Cilostazol 1028-163 · A130
Clinical outcomes 2504-503 · A210








bioabsorbable 2502-437 · A193
Drug-eluting stent, nonpolymeric 2502-419 
· A192
Drug-eluting stent, paclitaxel 2503-422 · 
A199
Drug-eluting stent, sirolimus 2505-522 · 
A217
Drug-eluting stent, zotarolimus 2504-503 
· A210
Dynamic left ventricular outflow tract 
obstruction 1052-321 · A106
Dyslipidemia 0904-03 · A47
Dyspnea 0922-07 · A17
Dyssynchrony 1259-238 · A95
E/Em ratio 1261-245 · A95
Early discharge 2502-515 · A197
Early invasive strategy 1250-172 · A143
Early repolarization 1243-127 · A13
Echocardiographic assessment 1171-384 
· A149
Echocardiographic strain 0923-04 · A66
Echocardiography 1253-192 · A91
Echocardiography transesophageal, 
3-dimensional 0909-03 · A64
Echocardiography transesophageal, 
3-dimensional, real-time 1226-382 · 
A151
Echocardiography, 3-dimensional 1094-234 
· A77
Echocardiography, Doppler 0909-05 · A64
Echocardiography, exercise stress 1236-84 
· A38
Echocardiography, intracardiac 1079-136 
· A5
Echocardiography, transthoracic, 
2-dimensional 1259-238 · A95
Economic impact 1030-173 · A131
Edema 1239-102 · A61
Education 1087-183 · A135
Efficiency 1030-173 · A131
Eisenmenger syndrome 1119-404 · A42
Ejection fraction 1207-251 · A90
Ejection fraction, preserved 1071-84 · A26
Elderly 1140-171 · A137
Electroanatomic map 1243-125 · A13
Electrocardiogram, 12-lead 2502-508 · 
A197
Electrocardiogram, characteristics 1067-51 
· A23
Electrocardiography 0906-06 · A1
Electronic clinical decision 
support 1032-186 · A132
Electrophysiology 1243-125 · A13
Electrophysiology study 1001-21 · A219
Embolic protection device 1110-341 · 
A160
Emergency care 1196-177 · A141
Emergency room 1208-261 · A118
Cyclo-oxygenase 1274-351 · A175
Cystatin C 1128-93 · A54
Cytokine 1015-70 · A20
D-dimer 1165-346 · A166
Decompensation 1123-55 · A28
Defibrillation 1106-317 · A111
Defibrillation threshold testing 1189-129 
· A10
Defibrillator 1188-126 · A10
Defibrillator, implantable 1189-135 · A11
Delayed enhancement cardiac magnetic 
resonance 1152-251 · A84
Depolarization 1157-291 · A115
Depression 1132-119 · A57
Desensitization 1012-50 · A19
Detection 1229-408 · A45
Device 1191-150 · A12
Device closure 2505-432 · A212
Device therapy 0916-06 · A17
Device trial 1083-162 · A133
Diabetes mellitus 1270-321 · A128
Diagnosis 1156-282 · A114
Diagnostic accuracy 1134-130 · A8
Diagnostic performance 1254-203 · A92
Dialysis 2903-09 · A179
Diastole 1259-234 · A94
Diastolic dysfunction 1016-85 · A22
Diastolic heart failure 1123-57 · A28
Diet 1129-98 · A55
Direct current cardioversion 1097-254 · 
A79
Direct thrombin inhibitor 2504-432 · A206
Disease management programs 1247-157 
· A142
Disparity 1082-154 · A133
Distal embolization 2905-07 · A180
Distal protection device 2501-490 · A188
Distensibility 1053-327 · A155
Dobutamine 1260-241 · A95
Dobutamine stress 
echocardiography 1261-245 · A95
Dobutamine stress testing 1212-292 · 
A121
Dofetilide 1023-121 · A2
Dominant frequency 1079-132 · A5
Door-to-balloon time 2501-431 · A185
Doppler echocardiography 1198-192 · A85
Doxorubicin 1175-38 · A31
Drug 1021-109 · A50
Drug interactions 1074-99 · A52
Drug safety assessment 1021-113 · A50
Drug therapy 2504-490 · A209
Drug-eluting stent 2502-420 · A192
Drug-eluting stent restenosis 1214-305 · 
A122
Drug-eluting stent thrombosis 2501-520 
· A191
Contrast 1192-155 · A139
Contrast agents 1033-192 · A67
Contrast echocardiography 1035-211 · 
A69
Contrast-induced nephropathy 2504-507 
· A210
Coronary anatomy 1281-407 · A46
Coronary angiography 1095-240 · A78
Coronary angiography, 
quantitative 1033-193 · A67
Coronary artery 1058-365 · A158
Coronary artery aneurysm 2904-08 · A180
Coronary artery atherosclerosis 1090-208 
· A75
Coronary artery bypass grafting 0924-04 
· A98
Coronary artery bypass grafting, 
prior 2501-507 · A190
Coronary artery calcification 1039-236 · 
A71
Coronary artery calcification 
score 1042-255 · A73
Coronary artery disease 1095-240 · A78
Coronary artery disease, chronic 1269-317 
· A128
Coronary artery disease, high 
risk 2504-497 · A209
Coronary artery disease, 
multivessel 2502-522 · A198
Coronary artery disease, stable 1213-299 
· A121
Coronary artery flow 1167-361 · A167
Coronary artery plaque burden 1112-360 
· A162
Coronary artery stenosis 1034-201 · A68
Coronary artery, left main 1001-6 · A218
Coronary atheromatous 
regression 1167-362 · A167
Coronary flow reserve 1258-229 · A94
Coronary flow velocity 2501-494 · A189
Coronary flow velocity reserve 2503-520 
· A204
Coronary heart disease 1075-105 · A53
Coronary lesion, calcific 1277-371 · A177
Coronary lesion, complex 2904-06 · A180
Coronary microcirculatory 
dysfunction 0917-05 · A66
Coronary risk 1187-115 · A59
Coronary sinus 0919-07 · A98
Coronary stent implantation 2503-457 · 
A201
Corticosteroids 1136-150 · A9
Cost 1010-36 · A18
Cost analysis 1229-407 · A45
Cost effectiveness 1082-156 · A133
Creatinine 1162-323 · A118
Critical limb ischemia 1057-358 · A158
Cryoablation 1134-129 · A8
Culprit lesion 2501-503 · A190
JACC    March 9, 2010  Subject Index A313 
Subject Index
Heart failure, incident 1124-68 · A29
Heart failure, New York Heart Association 
class I and II 1068-58 · A24
Heart failure, preserved ejection 
fraction 1236-81 · A38
Heart rate 1217-322 · A123
Heart rate recovery 0406-4 · A222
Heart surgery 0903-06 · A1
Heart transplantation 1012-49 · A19
Heart-fatty acid binding protein 1020-107 
· A50
Hematocrit 1156-289 · A115
Hemodialysis 1062-387 · A146
Hemodynamics 1052-320 · A106
Hemorrhage, intraplaque 1276-368 · A176
Hemorrhagic complications, 
critical 2505-496 · A215
Heparin 2504-421 · A205
High risk 1213-297 · A121
High-density lipoprotein 0904-03 · A47
High-density lipoprotein 
cholesterol 1273-342 · A174
High-risk surgical candidates 2904-10 · 
A180
Homocysteine 1128-95 · A55
Hormones 0915-06 · A153
Hospital readmission 1140-171 · A137
Hospitalization 1123-56 · A28
Human immunodeficiency virus 1218-324 
· A168
Hydrogen sulfide 1158-297 · A116
Hypercholesterolemia 1170-377 · A149
Hyperglycemia 2501-494 · A189
Hyperlipidemia 1169-370 · A168
Hypertension 1239-98 · A61
Hypertension, essential 1029-169 · A131
Hypertrophic cardiomyopathy 1096-246 · 
A78
Hypertrophic cardiomyopathy 
carriers 1122-51 · A27
Hypertrophic obstructive 
cardiomyopathy 2907-05 · A181
Hypertrophy 0402-02 · A222
Hypoplastic left heart syndrome 1228-398 
· A44
Hypothermia 1013-58 · A20
Hypoxia 1035-205 · A68
Imaging 2505-534 · A217
Imaging, aortic 1063-392 · A40
Imaging, molecular 2501-462 · A188
Immunoglobulin 1273-347 · A175
Immunological correlates 1228-397 · A44
Immunosuppression 1012-48 · A19
Impella 1065-35 · A22
Implantable 
cardioverter-defibrillator 1191-146 · A12
In-stent restenosis 2503-464 · A202
Incidence 1242-119 · A63
Fluorodeoxyglucose positron emission 
tomography 1148-232 · A82
Foam cells 1164-337 · A165
Follow-up 0918-04 · A129
Fontan 0907-06 · A39
Fractional flow reserve 1268-307 · A127
Fractional flow reserve, coronary 2503-502 
· A203
Fracture 1086-178 · A135
Fragmented QRS complex 0906-05 · A1
Framingham risk score 1258-232 · A94
Functional status 1056-353 · A157
Functional stenosis 2503-502 · A203
Gastrointestinal 0908-04 · A47
Gender 1029-170 · A131
Gene analysis 1231-42 · A35
Gene expression profiling 1024-132 · A3
Gene polymorphisms 1014-65 · A20
Gene polymorphisms, interaction 
among 1222-359 · A171
Gene therapy 1078-126 · A5
Genetic association studies 1222-359 · 
A171
Genetic mutation 1230-37 · A35
Genetic polymorphism 1263-263 · A124
Genetics 1230-37 · A35
Geometry 1060-377 · A146
Geriatric assessment 1227-391 · A151
Glomerular filtration rate 1073-96 · A52
Glucagon-like peptide 1132-116 · A57
Glucose 1049-303 · A104
Glucose levels 2502-458 · A195
Glucose tolerance, impaired 1183-93 · 
A58
Glycoprotein IIb/IIIa inhibitor 2504-422 · 
A205
Glycosylated hemoglobin 1249-168 · A143
Growth factor 1181-82 · A34
Growth-differentiation factor-15 1070-70 
· A25
Guidelines 1060-379 · A146
Guidelines implementation 1191-146 · 
A12
Health knowledge 1196-177 · A141
Healthy people 1147-222 · A82
Heart 1104-306 · A110
Heart block 1116-384 · A148
Heart disease, valvular 1170-377 · A149
Heart failure 1014-65 · A20
Heart failure management 1126-82 · A30
Heart failure outcome 1140-171 · A137
Heart failure therapy, 
guideline-recommended 1235-70 · A37
Heart failure, acute 1196-177 · A141
Heart failure, chronic 1146-218 · A81
Heart failure, diastolic 1236-84 · A38
Heart failure, experimental 1014-61 · A20
Encapsulation 1001-1 · A218
End-stage renal disease 1194-169 · A140
Endocarditis 1177-51 · A32
Endothelial 1130-103 · A55
Endothelial cell 1002-27 · A220
Endothelial dysfunction 1132-115 · A56
Endothelial injury 2505-509 · A216
Endothelial nitric oxide synthase 1212-291 
· A120
Endothelial progenitor cell 1063-396 · A40
Endothelin 1057-362 · A158
Endothelin-1 1027-154 · A130
Endothelium 1274-352 · A175
Endovascular therapy 1057-358 · A158
Enhanced external 
counterpulsation 1169-374 · A168
Enoxaparin 1073-93 · A51
Eosinophil cationic protein 1165-341 · 
A165
Epicardial adipose tissue 1038-229 · A70
Epicardial fat 1091-218 · A76
Epidemiology 1098-259 · A106
Erectile dysfunction 1269-316 · A128
Erythropoiesis-stimulating 
agents 1102-292 · A109
Esophageal injury 1079-129 · A5
Estrogen 1236-82 · A38
Ethnicity 1242-118 · A63
Etiology 1152-257 · A112
EuroScore 1061-381 · A146
Exercise 1132-119 · A57
Exercise capacity 1014-68 · A20
Exercise echocardiography 1200-210 · A86
Exercise intervention 1187-117 · A59
Exercise test 1144-197 · A80
Exercise training 1119-402 · A42
Exercise treadmill testing 1200-206 · A86
Expired gas analysis 1180-75 · A34
External counterpulsation 1002-26 · A220
Extracellular matrix processing 1015-76 
· A21
Extracorporeal membrane 
oxygenation 1174-405 · A43
Ezetimibe 1019-100 · A49
Fabry cardiomyopathy 1175-35 · A30
Factor Xa 1073-93 · A51
Familial hypercholesterolemia 1017-86 · 
A48
Fat mass and obesity 1143-188 · A79
Feasibility and safety 2503-493 · A202
Femoropopliteal 1059-370 · A159
Fiber orientation 1228-392 · A44
Fibrate 1019-101 · A49
Fibrinolysis 1047-291 · A103
Finance, patient 1252-184 · A144
First-in-man study 2904-05 · A179
Flow cytometry 1086-179 · A135








subfraction 1075-105 · A53
Lymphocytes 1218-325 · A168
Magnetic navigation 1136-149 · A9
Magnetic resonance 1104-302 · A110
Magnetic resonance imaging 1054-335 · 
A156
Magnetic resonance imaging, 
cardiovascular 1064-407 · A41
Magnetic resonance imaging, 
contrast-enhanced 1152-252 · A84
Magnetic resonance imaging, delayed 
enhancement 1234-65 · A37
Major adverse cardiac events 1089-201 
· A74
Major bleeding 1195-172 · A140
Mapping 1190-138 · A11
Marfan syndrome 1063-393 · A40
Matricellular proteins 1071-79 · A26
Matrix proteases 1219-339 · A169
Medical therapy 1057-358 · A158
Medication adherence 1088-188 · A73
Mediterranean diet 1132-117 · A57
Mental health 1196-180 · A141
Mesenchymal stem cells 2505-509 · A216
Meta-analysis 1094-234 · A77
Metabolic 1209-268 · A119
Metabolic intervention 1262-252 · A96
Metabolic syndrome 1132-115 · A56
Metabolism 1015-75 · A21
Metformin 1175-38 · A31
Microalbuminuria 1194-170 · A140
Microbubbles 1035-208 · A68
Microcirculation 1237-90 · A60
Microparticle 2501-455 · A187
MicroRNA 1015-74 · A21
Microvascular 1103-298 · A110
Microvascular dysfunction 2503-521 · 
A204
Microvascular injury 0911-03 · A65
Microvascular resistance 2503-491 · A202
Microvasculature 1047-294 · A103
Mitochondrial dysfunction 0406-1 · A222
Mitogen-activated protein kinases 1002-32 
· A220
Mitral annular calcification 1090-205 · A74
Mitral annulus 1133-125 · A7
Mitral prolapse 1060-375 · A146
Mitral regurgitation 1032-187 · A132
Mitral regurgitation, functional 1039-237 
· A71
Mitral regurgitation, severe 0909-04 · A64
Mitral stenosis 2901-10 · A178
Mitral valve 0408-4 · A223
Mitral valve disease 0902-04 · A145
Mitral valve prolapse 1226-382 · A151
Mitral valve repair 0902-03 · A145
Left atrial appendage, occluder 
device 2907-07 · A181
Left atrial appendage, thrombogenic 
milieu 1078-121 · A4
Left atrial catheter ablation 1080-142 · A6
Left atrial dilation 1092-222 · A76
Left atrial function 1152-255 · A85
Left atrial pressure 1254-204 · A92
Left atrial strain 0923-05 · A66
Left atrial volume 1253-191 · A91
Left atrial volume index 0923-05 · A66
Left atrium 1097-253 · A79
Left bundle branch block 1025-143 · A3
Left main coronary artery 2502-496 · 
A196
Left main coronary artery disease 2906-10 
· A181
Left main coronary artery 
occlusion 1050-311 · A105
Left main trunk disease 2502-502 · A197
Left ventricle 1253-192 · A91
Left ventricular assist device 1032-187 · 
A132
Left ventricular diastolic function 1152-255 
· A85
Left ventricular dysfunction 1198-194 · 
A85
Left ventricular dyssynchrony 1235-69 · 
A37
Left ventricular ejection fraction 0917-04 
· A66
Left ventricular function 1024-132 · A3
Left ventricular geometry 1183-94 · A58
Left ventricular hypertrophy 0903-03 · A1
Left ventricular mass 1020-103 · A49
left ventricular mechanics 1262-254 · A96
Left ventricular remodeling 1216-316 · 
A123
Left ventricular strain 1198-194 · A85
Left ventricular systolic 
dysfunction 1193-161 · A139
Left ventricular torsion 1151-249 · A84
Length of stay 1153-262 · A113
Lifestyle 1132-115 · A56
Lipid core 2902-10 · A179
Lipid levels 1072-88 · A51
Lipid-lowering therapy 1076-112 · A53
Lipoprotein(a) 1075-104 · A52
Lipoprotein-associated phospholipase 
A2 1164-335 · A165
Lipoproteins 1017-87 · A48
Long QT syndrome 1027-158 · A130
Long-term follow-up 2505-457 · A214
Long-term result 2502-502 · A197
Low-density lipoprotein 1075-107 · A53
Low-density lipoprotein 
cholesterol 1075-107 · A53
Incident heart failure 1124-65 · A29
Infarct size 1104-304 · A110
Infarction 0906-06 · A1
Infection 1189-132 · A11
Infective endocarditis 1062-388 · A147
Inflammation 1182-90 · A57
Inflammatory biomarkers 1274-352 · A175
Inflammatory cardiomyopathy 1231-45 · 
A35
Inflammatory plaque 1098-257 · A106
Insulin 1186-109 · A59
Insulin resistance 1183-92 · A57
Insulin sensitivity 1164-334 · A165
Integrated backscatter intravascular 
ultrasound 1112-362 · A163
Interleukin-1 receptor antagonist 1045-278 
· A102
Interstage mortality 1280-393 · A45
Intervention 2505-430 · A212
Intervention, coronary 2503-432 · A199
Interventional cardiology 1280-398 · A45
Intima-media thickness 1219-339 · A169
Intra-aortic balloon pump 1159-303 · A116
Intracardiac echocardiography 1190-143 
· A12
Intracoronary ultrasound 2505-534 · A217
Intraoperative 2505-421 · A212
Intraplaque hemorrhage 1163-328 · A164
Intravascular optical sensor 1112-361 · 
A162
Intravascular ultrasound 2503-502 · A203
Intravascular ultrasound/
Doppler 2503-491 · A202
Intraventricular conduction delay 0916-05 
· A17
Invasive therapy 2505-496 · A215
Iron 1179-61 · A33
Iron overload 1003-552 · A221
Ischemia 1091-215 · A75
Ischemia-reperfusion injury 1160-311 · 
A117
Ischemic heart disease 1104-302 · A110
Ischemic pre-conditioning 1157-291 · 
A115
Kawasaki disease 1108-329 · A160
Kidney disease 1131-110 · A56
Kidney disease, chronic 1189-135 · A11
Kidney injury, acute 1046-282 · A102
Kidney transplant 1234-63 · A37
Late gadolinium enhancement 1150-242 
· A84
Late sodium current 1023-127 · A2
Late stent thrombosis 2908-08 · A182
Lead extraction 1189-133 · A11
Left anterior descending coronary 
artery 2502-463 · A195
Left atrial 1242-117 · A62
Left atrial appendage 0903-07 · A1
JACC    March 9, 2010  Subject Index A315 
Subject Index
Optical coherence tomography 2503-463 
· A202
Osteoporosis 1130-106 · A56
Out-of-hospital cardiac arrest 1105-311 · 
A111
Outcome assessment 2502-514 · A197
Outcomes 1128-96 · A55
Outcomes research 1010-38 · A18
Outcomes, adverse 1236-78 · A38
Outcomes, cardiovascular 0914-06 · A98
Outcomes, in-hospital 0408-1 · A223
Outcomes, long-term 1207-251 · A90
Outcomes, pediatric cardiac 
surgery 1228-399 · A44
Outpatient 0918-03 · A129
Overweight 1143-192 · A79
Oxidative stress 1003-549 · A221
Oxidized low-density lipoprotein 1019-100 
· A49
Pacemaker 1078-126 · A5
Pacing 1134-130 · A8
Pacing lead location 1024-136 · A3
Pacing, biventricular, optimization 1068-53 
· A23
Paclitaxel 2505-523 · A217
Papillary muscles 1190-137 · A11
Paravalvular leak 1225-376 · A150
Patent foramen ovale 2505-432 · A212
Pathologic study 2501-508 · A190
Patient knowledge 2502-517 · A198
Patient satisfaction 1191-150 · A12
Patterns of care in population 2501-521 
· A191
Pediatric cardiology 1280-398 · A45
Pediatrics 1229-407 · A45
Percutaneous 1225-376 · A150
Percutaneous aortic valve 
replacement 1225-375 · A150
Percutaneous aortic valve replacement, 
transfemoral 1059-372 · A159
Percutaneous coronary 
intervention 2504-494 · A209
Percutaneous coronary intervention 
trend 2502-506 · A197
Percutaneous coronary intervention, 
elective 1214-305 · A122
Percutaneous coronary intervention, 
primary 2501-447 · A187
Percutaneous coronary intervention, 
strategies 2501-490 · A188
Percutaneous coronary intervention, 
transradial 2505-455 · A214
Percutaneous transluminal coronary 
angioplasty 1248-164 · A142
Percutaneous ventricular assist 
device 2904-10 · A180
Percutanous heart failure therapy 0913-07 
· A16
Perforation 2505-420 · A212
Myocardial scar 1234-65 · A37
Myocarditis 1231-43 · A35
Myocarditis, acute 1174-405 · A43
Myocardium 1096-249 · A78
N-terminal pro-B-type natriuretic 
peptide 1071-85 · A26
National Health and Nutrition Examination 
Survey 1053-324 · A155
Natriuretic peptide 1239-101 · A61
Natriuretic peptide, N-terminal 
pro-B-type 1242-118 · A63
Near-infrared spectroscopy 1258-228 · 
A94
Nebivolol 1235-76 · A38
Neointima 2503-463 · A202
Neointimal coverage 2505-522 · A217
Neointimal hyperplasia 2505-523 · A217
Neonatal 1104-306 · A110
Neopterin 1263-256 · A123
Neovascularization 1055-342 · A156
Nephropathy 2504-517 · A211
Nephropathy, contrast-induced 2504-518 
· A211
Neurohumoral markers 1146-216 · A81
New devices 1133-126 · A7
New onset 1134-133 · A8
Nitric oxide 1069-64 · A24
Nitroglycerin 1070-69 · A25
No-reflow phenomenon 2501-489 · A188
Non-high density lipoprotein 
cholesterol 1274-357 · A175
Non–ST-segment elevation acute coronary 
syndromes 1156-284 · A115
Non–ST-segment elevation myocardial 
infarction 1049-305 · A104
Nonagenarians 2504-498 · A209
Noncompaction cardiomyopathy 1173-396 
· A43
Noninvasive cardiology 1278-375 · A151
Noninvasive diagnostic testing 1091-214 
· A75
Nonischemic cardiomyopathy 1068-57 · 
A24
Nonsteroidal anti-inflammatory 
drugs 1165-346 · A166
Norepinephrine 1052-321 · A106
Norwood surgery 1228-398 · A44
Nuclear cardiology 1207-251 · A90
Nurse practitioners 1087-183 · A135
Obesity 1137-155 · A136
Obesity, central 1242-119 · A63
Obesity, childhood 1173-393 · A42
Obstructive sleep apnea 1209-271 · A119
Off-label use 1214-305 · A122
Off-pump coronary artery bypass 
grafting 0902-07 · A145
Omega-3 fatty acids 1244-136 · A13
Mitral valve surgery 0902-03 · A145
Mitral valvuloplasty, 
percutaneous 1060-375 · A146
Molecular biology 1014-62 · A20
Molecular imaging 1035-208 · A68
Monitoring 1246-152 · A15
Monocyte-endothelial interaction 1273-345 
· A174
Morbidity 1003-546 · A220
Mortality 1236-81 · A38
Mortality, in-hospital 1211-285 · A120
Mortality, long-term 1265-274 · A125
Mouse model 1013-53 · A19
Multi-Ethnic Study of Atherosclerosis 
(MESA) 1095-242 · A78
Multidisciplinary protocol 1125-70 · A29
Multivessel disease 2505-446 · A213
Multivessel percutaneous coronary 
intervention 1195-174 · A140
Multivessel revascularization 2911-06 · 
A184
Mustard procedure, adult 
patients 1064-404 · A41
Myocardial 1278-376 · A152
Myocardial blush grade 0911-03 · A65
Myocardial bridging 2502-463 · A195
Myocardial damage 2902-10 · A179
Myocardial deformation imaging 1096-247 
· A78
Myocardial delayed 
enhancement 1147-223 · A82
Myocardial fibrosis 1016-79 · A21
Myocardial flow reserve 1202-222 · A87
Myocardial function 1199-197 · A85
Myocardial hemorrhage 0911-06 · A65
Myocardial infarction 1041-247 · A72
Myocardial infarction, acute 1265-274 · 
A125
Myocardial infarction, chronic 1190-138 
· A11
Myocardial infarction, treatment 1001-10 
· A218
Myocardial ischemia 1275-360 · A176
Myocardial ischemia/
reperfusion 1216-316 · A123
Myocardial mechanics 1159-303 · A116
Myocardial perfusion 1203-230 · A88
Myocardial perfusion imaging 1041-247 
· A72
Myocardial perfusion imaging, 
pharmacologic stress 1035-209 · A68
Myocardial perfusion imaging, 
single-photon emission computed 
tomography 1204-238 · A89
Myocardial regeneration 1013-52 · A19
Myocardial remodeling 1147-223 · A82
Myocardial revascularization 1269-313 · 
A127
Myocardial salvage 1045-280 · A102







Readmission 1251-180 · A144
Real world 2501-522 · A191
Reconstruction software 1042-253 · A72
Recurrence 1136-153 · A9
Regeneration 1056-350 · A157
Regionalized STEMI care 1101-286 · A109
Registries 2502-510 · A197
Rehabilitation 1125-72 · A29
Remodeling 2503-492 · A202
Remodeling, adverse 1070-76 · A25
Remodeling, atrial 1167-362 · A167
Remodeling, cardiac 1144-203 · A80
Remodeling, vascular 1039-236 · A71
Remodeling, ventricular 1014-62 · A20
Renal 1194-168 · A140
Renal artery stenosis 1109-334 · A160
Renal disease 1111-353 · A162
Renal dysfunction 2501-500 · A189
Renal failure 1209-266 · A119
Renal failure, end-stage 0916-07 · A17
Renal function 1132-117 · A57
Renal insufficiency 1126-85 · A30
Renal insufficiency, chronic 1208-260 · 
A118
Renin-angiotensin system 0406-2 · A222
Renin-angiotensin system blocker 1239-99 
· A61
Repair 0902-06 · A145
Reperfusion 1099-271 · A107
Reperfusion injury 1159-302 · A116
Reperfusion therapy 1044-269 · A101
Resource utilization 1088-193 · A73
Respiration 1126-81 · A30
Restenosis 2502-437 · A193
Restenosis, in-stent 2503-435 · A200
Restenosis, late 2502-446 · A194
Resuscitation 1106-317 · A111
Resynchronization therapy 0923-04 · A66
Retrograde 2505-464 · A214
Revascularization 1112-360 · A162
Revascularization, combined 2906-10 · 
A181
Revascularization, culprit lesion 2503-422 
· A199
Revascularization, multivessel 0914-03 · 
A97
Reverse remodeling 1001-14 · A219
Rheumatic 1278-376 · A152
Rheumatoid arthritis 1258-231 · A94
Rho kinase 1107-323 · A112
Right bundle branch block 1024-131 · A2
Right heart abnormalities 1228-393 · A44
Right heart catheterization 1223-368 · 
A172
Right ventricle 1093-229 · A76
Right ventricular dysfunction 1147-226 · 
A82
Prediction 1244-129 · A13
Prediction score 1085-174 · A134
Predictors 1139-166 · A137
Predictors of mortality 1187-116 · A59
Pregnancy 1118-395 · A41
Premature ventricular complex 1190-140 
· A11
Pressure overload 1020-104 · A49
Prevalence 0908-04 · A47
Prevention 1129-98 · A55
Primary prevention 1195-173 · A140
Progenitor cells 1069-64 · A24
Prognosis 2503-520 · A204
Prognostic factor 0920-04 · A129
Propensity score 1127-86 · A54
Prosthetic heart valve 1063-397 · A40
Proton pump inhibitors 1074-99 · A52
Proximal embolic protection and 
aspiration 2911-10 · A184
Psychological 1141-178 · A138
Pulmonary artery 1198-192 · A85
Pulmonary artery systolic 
hypertension 1199-197 · A85
Pulmonary embolism 1199-198 · A86
Pulmonary hypertension 1147-226 · A82
Pulmonary regurgitation 1280-395 · A45
Pulmonary valve replacement 1225-378 
· A150
Pulmonary valve therapies, 
percutaneous 2505-420 · A212
Pulmonary vein anatomy 1174-403 · A43
Pulmonary vein isolation 1126-80 · A30
Pulmonary vein stenosis 1136-152 · A9
Pulse pressure 1234-61 · A37
Pulse volume recording 1053-329 · A155
Pulse wave velocity 1114-374 · A164
Pulse wave velocity, aortic 0905-07 · A64
QRS notching 1244-130 · A13
QT interval 1078-127 · A5
Quality 1249-169 · A143
Quality of care 1251-180 · A144
Quality of life 2905-09 · A180
Quantitative coronary 
angiography 1034-201 · A68
Race 2504-495 · A209
Racial disparities 1269-315 · A128
Radial access 2505-458 · A214
Radial artery 0924-04 · A98
Radiation 2505-419 · A211
Radiation dose 1034-204 · A68
Radiation dose reduction 1034-198 · A68
Radionuclide imaging 0917-04 · A66
Randomized blinded controlled 
trial 2910-07 · A183
Randomized clinical trial 2502-420 · A192
Ranolazine 1099-265 · A107
Re-entry 1036-221 · A69
Performance indicator 1082-158 · A133
Perfusion imaging 1042-253 · A72
Pericardial fat 1040-239 · A71
Pericardiocentesis 1121-42 · A27
Pericarditis 1067-49 · A23
Perioperative management 1249-169 · 
A143
Peripheral arterial disease 1053-329 · 
A155
Peripheral arterial occlusive 
disease 1109-340 · A160
Peripheral limb ischemia 2505-451 · A213
Peripheral vascular intervention 1059-374 
· A159
Pharmacogenetics 1154-266 · A113
Pharmacogenomic 1048-296 · A103
Pharmacological stress 1082-157 · A133
Phase analysis of gated myocardial 
perfusion SPECT 1204-234 · A89
Phase-contrast 1122-47 · A27
Physiogenomics 2504-490 · A209
Pioglitazone 1018-93 · A48
Plaque 2501-437 · A186
Plaque composition 2503-455 · A201
Plaque instability 1163-328 · A164
Plaque regression 1219-333 · A169
Plaque rupture 1098-257 · A106
Plaque volume 1042-251 · A72
Plaque, coronary 1102-294 · A109
Plaque, inflammatory 1263-260 · A124
Plaque, nonobstructive 1088-189 · A73
Plaque, vulnerable 1110-342 · A161
Plasma biomarkers 0912-04 · A97
Platelet 2505-439 · A213
Platelet aggregation 1221-353 · A171
Platelet function 1169-372 · A168
Platelet function testing 1100-280 · A108
Platelet inhibition 2504-455 · A207
Platelet reactivity 1075-106 · A53
Point of care testing 2504-450 · A207
Polymer 1086-179 · A135
Polymorphism 1028-163 · A130
Population research 1039-235 · A71
Population studies 0925-05 · A154
Positron emission tomography 0917-03 · 
A65
Positron emission tomography, 
Fluorodeoxyglucose 1205-239 · A89
Post-ischemic diastolic 
dysfunction 1256-217 · A93
Posterior wall 2501-450 · A187
Potassium channels 1078-127 · A5
Pre-conditioning 1169-372 · A168
Pre-hospital electrocardiogram 2501-430 
· A185
Pre-hypertension 1185-107 · A59
Pre-load 1254-197 · A91
JACC    March 9, 2010  Subject Index A317 
Subject Index
Surgical ventricular reconstruction/
restoration 1092-224 · A76
Survey 1191-146 · A12
Survival 1126-85 · A30
Sympathetic function 0913-05 · A16
Sympathetic nervous system 1205-241 · 
A89
Synchrony 1139-168 · A137
Syncope 1025-141 · A3
Syntax score 1085-171 · A134
Systemic lupus erythematosus 1108-325 
· A159
Systolic dysfunction 0906-05 · A1
Systolic function 0910-03 · A16
T-lymphocytes 1277-374 · A177
Takayasu’s aortitis 1108-326 · A159
Takotsubo 1113-366 · A163
Tamponade 2502-534 · A199
Tandem heart 1065-35 · A22
Telemedicine 1032-185 · A132
Tethering 1145-212 · A81
Tetralogy of Fallot 1064-405 · A41
Thalassemia major 1150-239 · A83
Therapeutic substitution 1030-173 · A131
Therapy 1069-64 · A24
Thiazolidinedione 1055-347 · A157
Thin-capped fibroatheroma 2902-07 · 
A178
Three-dimensional 0909-04 · A64
Three-dimensional 
reconstruction 2501-514 · A190
Thrombectomy 2501-491 · A188
Thrombin inhibitors 1078-123 · A4
Thromboembolism 1224-374 · A173
Thrombogenicity 1040-242 · A71
Thrombolysis 1051-313 · A105
Thrombolytic therapy 2504-491 · A209
Thrombosis 1271-325 · A173
Thrombosuction 1274-353 · A175
Thrombus 1264-268 · A124
Thrombus aspiration 1274-356 · A175
Thrombus, left atrial 1080-141 · A6
Time to reperfusion 1106-315 · A111
Tissue Doppler imaging 1097-252 · A79
Tissue Doppler imaging, 
transthoracic 1236-84 · A38
Tissue engineering 1013-52 · A19
Tissue strain imaging 1253-193 · A91
Torsade de pointes 1023-126 · A2
Torsion 1258-229 · A94
Transapical aortic valve 
replacement 2505-515 · A216
Transcatheter 1116-382 · A147
Transcatheter aortic valve 
replacement 2505-435 · A212
Transcatheter closure 2505-429 · A212
Transcatheter intervention 2907-05 · A181
ST-segment elevation myocardial 
infarction 2501-431 · A185
ST-segment elevation myocardial infarction 
network 1101-285 · A109
ST-segment elevation myocardial infarction, 
acute 1101-285 · A109
ST-segment elevation myocardial infarction, 
anterior 2909-08 · A183
ST-segment resolution 1044-268 · A101
ST-segment resolution, immediate 0408-3 
· A223
Stable coronary disease 1217-322 · A123
Statin therapy 1018-92 · A48
Statin-treated population 1030-172 · A131
Stem cell therapy 1069-61 · A24
Stem cells 1013-52 · A19
Stem cells, adult 1275-359 · A176
Stenosis, coronary artery 2504-467 · 
A208
Stent 1161-313 · A117
Stent apposition, incomplete 2501-514 · 
A190
Stent fracture 1215-308 · A122
Stent implantation 1161-314 · A117
Stent thrombosis 1153-261 · A113
Stent thrombosis, late 2502-494 · A196
Stent, bioabsorbable 2503-495 · A202
Stent, drug-eluting 2504-494 · A209
Stent, kissing 2503-501 · A203
Stent, self-expandable 1050-308 · A105
Stenting, carotid artery 2905-05 · A180
Stenting, coronary 1154-271 · A113
Strain echocardiography 1279-385 · A152
Strain imaging 1152-253 · A84
Strain imaging, 2-dimensional 1199-198 
· A86
Strain rate 1259-237 · A95
Stress 1060-377 · A146
Stress echocardiography 1260-239 · A95
Stress myocardial perfusion SPECT 
imaging 1031-177 · A132
Stress testing 0917-04 · A66
Stress testing, contrast 
echocardiography 1119-407 · A42
Stress testing, dobutamine/
atropine 1151-245 · A84
Stress, chronic 1277-370 · A176
Stroke 1256-215 · A93
Stroke prevention 1110-342 · A161
Stroke, acute ischemic 1171-383 · A149
Subclinical atherosclerosis 1017-87 · A48
Subclinical inflammation 1018-94 · A48
Sudden cardiac death 1281-407 · A46
Sudden cardiac death, prevention 
of 2502-508 · A197
Supraventricular arrhythmias 1134-130 · 
A8
Surgery 1281-401 · A45
Right ventricular function 1064-407 · A41
Risk assessment 1265-278 · A125
Risk factor 1039-236 · A71
Risk factor management 1185-103 · A58
Risk factor, independent 2504-430 · A205
Risk model 1156-283 · A114
Risk prediction 1244-131 · A13
Risk reduction 1129-99 · A55
Risk score 2502-522 · A198
Risk stratification 1199-198 · A86
Risk, cardiovascular 1108-324 · A159
Rosuvastatin 1016-81 · A21
Rotation 1259-234 · A94
Rupture 2501-501 · A189
Rural healthcare 1129-99 · A55
Safety 1021-113 · A50
Saphenous vein graft 2504-421 · A205
Saphenous vein graft failure 2502-435 · 
A193
Sarcoplasmic reticulum 1070-69 · A25
Scar 1079-133 · A5
Scleroderma 1231-43 · A35
Screening 1063-395 · A40
Secondary prevention 1182-88 · A57
Secretory phospholipase A2 1164-339 · 
A165
Sepsis 1253-192 · A91
Serum uric acid levels 1162-320 · A118
Shear stress 1273-346 · A174
Shock therapy 1189-131 · A11
Side branch ostium 2503-495 · A202
Sildenafil 1002-33 · A220
Simulation 1032-187 · A132
Simvastatin 1232-47 · A36
Single ventricle 1280-393 · A45
Single-photon emission computed 
tomography 1205-240 · A89
Single-photon emission computed 
tomography myocardial perfusion 
imaging 1206-249 · A90
Single-photon emission computed 
tomography, gated 1204-235 · A89
Sirolimus 2502-422 · A193
Six-minute walk test 1223-366 · A172
Sleep apnea 1126-81 · A30
Sleep-disordered breathing 1126-82 · A30
Small vessel disease 2503-435 · A200
Smoking 1198-192 · A85
Socioeconomic disparities 1182-90 · A57
Socioeconomics 1182-90 · A57
Spasm 1167-359 · A167
Speckle tracking image, 
2-dimensional 1096-246 · A78
Speckle tracking imaging 1152-253 · A84
Spontaneously hypertensive rat 1166-353 
· A166
ST-segment elevation 1044-266 · A101







Vein graft 0924-05 · A99
Ventricular assist device 1052-320 · A106
Ventricular fibrillation 1052-323 · A106
Ventricular fibrillation, primary 1133-124 
· A7
Ventricular function 0910-05 · A16
Ventricular geometry 0910-03 · A16
Ventricular tachycardia 1190-141 · A11
Ventricular tachycardia/ventricular 
fibrillation 1065-37 · A22
Very long-term follow-up 2502-493 · A196
Viability 1268-310 · A127
Virtual histology 2902-09 · A179
Virtual histology intravascular 
ultrasound 2505-510 · A216
Viruses 1016-85 · A22
Vitamin D 1197-186 · A141
VO2, peak 1279-383 · A152
Volume outcome 1058-364 · A158
von Willebrand factor 1001-12 · A219
Wall motion abnormality 1262-255 · A96
Waon therapy 1056-352 · A157
Warfarin 1028-160 · A130
Wave reflection 1021-109 · A50
Weight loss 1167-362 · A167
Wolff-Parkinson-White syndrome 1134-131 
· A8
Women 1218-325 · A168
Young adult 1111-354 · A162
Uninsured, minority populations 0408-1 · 
A223
Universal definition 0912-05 · A97
Unstable coronary syndrome 1209-271 · 
A119
Uric acid 1081-150 · A7
Utilization 1229-403 · A44
Valvular 0901-07 · A145
Valvular disease 1170-378 · A149
Valvuloplasty 2901-09 · A178
Vascular 1194-168 · A140
Vascular access 2503-453 · A201
Vascular biology 1169-374 · A168
Vascular closure device 1059-372 · A159
Vascular complications 2505-495 · A215
Vascular disease 1001-18 · A219
Vascular dysfunction 0915-03 · A153
Vascular endothelial growth 
factor 1276-364 · A176
Vascular endothelial growth factor/
sFlt 0921-03 · A153
Vascular function 1237-89 · A60
Vascular redox 1022-118 · A51
Vascular repair 1022-115 · A50
Vascular smooth muscle cell 0402-03 · 
A222
Vascular stiffness 1114-370 · A163
Vasodilator 0910-04 · A16
Vasomotion 1148-230 · A82
Vasovagal syncope 1025-141 · A3
Transesophageal 
echocardiography 1108-325 · A159
Transfemoral aortic valve 
replacement 2505-515 · A216
Transfusion 2505-496 · A215
Transient ischemic attack 2907-06 · A181
Transient ischemic dilation 1207-252 · 
A90
Transplantation 1134-135 · A8
Transplantation, cardiac 2505-495 · A215
Transposition of the great 
arteries 1064-404 · A41
Transradial 2502-521 · A198
Treadmill test 1144-200 · A80
Treatment 0910-04 · A16
Treatment strategy 2502-460 · A195
Trend 1193-160 · A139
Tricuspid regurgitation 1223-366 · A172
Tricuspid valve 1093-232 · A77
Troponin 1208-259 · A118
Troponin I 1208-261 · A118
Tumor necrosis factor-alpha 1045-279 · 
A102
Ultrasound 2505-504 · A216
Ultrasound contrast 1035-205 · A68
Ultrasound contrast agents 1035-206 · 
A68
Ultrasound, intravascular, 
Doppler 1109-334 · A160
